Biosensing photonics platform for a precise, easy, fast and cheap SARS-CoV-2 virus diagnostic
Nº Project: 6 (Diari Oficial de la Generalitat Valenciana Num. 879_20.04.2020)
Title: Biosensing photonics platform for a precise, easy, fast and cheap SARS-CoV-2 virus diagnostic
COVID19 project main objective is the implementation of a simultaneous detection system for SARS-CoV-2 virus and IgG/IgM antibodies to be performed on the same photonic chip. Obtained information from that double detection will be of enormous interest for disease diagnostic and pandemic monitoring.
Within the scope of COVID19 project it is expected the detection of both types of analytes employing real samples obtained from Hospitals. The employed photonic chips are provided by NTC-MICRONANOFABS and they are chemically modified by LUMENSIA SENSORS. Photonic measurements are performed by means of a laboratory set-up. This will be considered as a proof of concept as a previous step before product industrialization.
COVID19 project allows a new strategic situation. Photonic chip design, whole value chain and 100% local technology against current situation where the dependence of foreign production is complete.
Lumensia would like to stablish strategic capacities for manufacturing their own detection test against current threats (COVID19) and the emerging ones that could come in the future, establishing a fast production of new photonic detection tests in few weeks if necessary. This will allow making provisions of a minimal critical stock of disposable cartridges and detection platforms to be ready for a rapid deployment against a new crisis since current tests and devices manufacturing is 100% foreigner.
What COVID19 project brings up in a medium period (1 year) is to change current situation to a 100% local production based in Valencia /Spain.